Vivos Therapeutics (VVOS) Income from Non-Controlling Interests (2026)
Vivos Therapeutics' (VVOS) quarterly Income from Non-Controlling Interests came in at -$69000.0 in Q1 2026.
Vivos Therapeutics (VVOS) Income from Non-Controlling Interests (2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 1 years of Income from Non-Controlling Interests data on file, last reported at -$69000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Vivos Therapeutics | 5.73 Mn | 3.62 Mn | 3.06 Mn | -69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69,000.00 |